Clinical characteristics and antibiotic resistance in children with invasive Acinetobacter baumannii infection
LIU Lin, DONG Lin, XU Yue-Bo, CHEN Zhao-Xing, FAN Jie-Min
Department of Respiratory Medicine, Yuying Children′s Hospital Affiliated to Wenzhou Medical College, Wenzhou, Zhejiang 325027, China. donglin0728@yahoo.com.cn
Abstract OBJECTIVE: To analyze the clinical characteristics and antibiotic resistance in children with invasive Acinetobacter baumannii infection (IABI). METHODS: A retrospective analysis was performed on the clinical and drug sensitivity data of 52 children with IABI between January 2004 and December 2011. RESULTS: Of the 52 children with IABI, 35 (67%) were less than one year old and 35 (67%) had IABI in the summer and autumn, 19 (37%) of these children were clinically diagnosed with septicemia, 16 (31%) with urinary tract infection, and 12 (23%) with skin and soft tissue infection, and 38 (73%) of them suffered from underlying diseases. The incidence rates of hospital-acquired and community-acquired IABIs were 90% and 10% respectively; 44 cases (85%) were cured or showed improvement in symptoms, and 8 cases (15%) died. All the IAB strains isolated from these children were sensitive to amikacin, 82% of them were sensitive to imipenem, more than 70% were sensitive to fluoroquinolone and to cefoperazone/sulbactam, 13% were sensitive to cefoperazone, 8% were sensitive to aztreonam, 21% developed multidrug resistance, and 17% developed pan-drug resistance. CONCLUSIONS: IABI occurs more frequently in children under one year of age, and most children with IABI have underlying diseases. IABI mainly results in septicemia, urinary tract infection and skin and soft tissue infection and is mostly hospital-acquired. Multi-drug resistance and pan-drug resistance are severe in IAB strains.
LIU Lin,DONG Lin,XU Yue-Bo et al. Clinical characteristics and antibiotic resistance in children with invasive Acinetobacter baumannii infection[J]. CJCP, 2013, 15(5): 379-382.
LIU Lin,DONG Lin,XU Yue-Bo et al. Clinical characteristics and antibiotic resistance in children with invasive Acinetobacter baumannii infection[J]. CJCP, 2013, 15(5): 379-382.
［2］Loivukene K, Kermes K, Sepp E, Adamson V, Mitt P, Jurna M, et al. The comparison of susceptibility patterns of Gramnegative invasive and non-invasive pathogens in Estonian hospitals［J］. Antonie Van Leeuwenhoek, 2006, 89(3-4): 367-371.
［3］Falagas ME, Karveli EA, Kelesidis I, Kelesidis T. Community-acquired Acinetobacter infections［J］. Eur J Clin Microbiol Infect Dis, 2007, 26(12): 857-868.
［5］Simmonds A, Munoz J, Aguero-Rosenfeld M, Carbonaro C, Montecalvo M, Clones B, et al. Outbreak of Acinetobacter infection in extremely low birth weight neonates［J］. Pediatr Infect Dis J, 2009, 28(3): 210-214.
［6］Punpanich W, Nithitamsakun N, Treeratweeraphong V, Suntarattiwong P. Risk factors for carbapenem non-susceptibility and mortality in Acinetobacter baumannii bacteremia in children［J］. Int J Infect Dis, 2012, 16(11): e811-e815.
［8］Saleem AF, Shah MS, Shaikh AS, Mir F, Zaidi AK. Acinetobacter species meningitis in children: a case series from Karachi, Pakistan［J］. J Infect Dev Ctries, 2011, 5(11): 809-814.
［9］Sebeny PJ, Riddle MS, Petersen K. Acinetobacter baumannii skin and soft-tissue infection associated with war trauma［J］. Clin Infect Dis, 2008, 47(4): 444-449.
［10］Ran YC, Ao XX, Liu L, Fu YL, Tuo H, Xu F. Microbiological study of pathogenic bacteria isolated from paediatric wound infections following the 2008 Wenchuan earthquake［J］. Scand J Infect Dis, 2010, 42(5): 347-350.
［11］Chang PY, Hsueh PR, Wu PS, Chan PC, Yang TT, Lu CY, et al. Multidrug-resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan［J］. J Microbiol Immunol Infect, 2007, 40(5): 406-410.
